Previous 10 | Next 10 |
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today released its 2023 Corporate Sustainability / Environment, Social and Governance (ESG) Report entitled Progress Takes Shape. Aptar’s report highlights key mil...
Places in top 1% of EcoVadis’ rankings for all industries AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies has achieved the Platinum level rating in recognition of its sustainability efforts from EcoVadis ...
2024-05-11 11:40:20 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2024-05-05 09:52:16 ET More on the markets S&P 500 1%+ Gaps Higher SPY: Don't Buy The Dip Just Yet Rate Hike Unlikely: Expect S&P 500 To Rally To New All-Time Highs Dovish Fed, 'Goldilocks' jobs report helps S&P 500 notch back-to-back weekly gains...
2024-05-02 16:50:11 ET Summary Silgan Holdings Inc.'s financial results for Q1 2024 were disappointing, with a decline in revenue and earnings compared to the previous year. The company's stock has dipped by 2.2% since my downgrade to a "Hold" rating, underperforming the S&P 5...
2024-04-26 15:14:05 ET AptarGroup, Inc. (ATR) Q1 2024 Earnings Conference Call April 26, 2024 09:00 ET Company Participants Mary Skafidas - Investor Relations Stephan Tanda - President & Chief Executive Officer Bob Kuhn - Executive Vice President & Chief ...
2024-04-25 17:20:34 ET More on AptarGroup AptarGroup, Inc. (ATR) Q4 2023 Earnings Call Transcript AptarGroup, Inc. 2023 Q4 - Results - Earnings Call Presentation AptarGroup Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating on AptarGroup His...
AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong first quarter results driven by continued growth of the company’s proprietary drug delivery systems, increased injectables sales and an improving ...
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...
2024-04-23 09:00:14 ET Aptargroup Inc. (ATR) declaring a stock dividend of $0.41 per share on Ex-Date : April 24, 2024. Shareholders on record as of April 25, 2024 are eligible for the dividend. The payment date is scheduled for May 16, 2024, and the declaration was officially made ...
News, Short Squeeze, Breakout and More Instantly...
AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Daniel Ackerman has been named Chief Accounting Officer, effective August 1, 2024. “Since joining Aptar over a decade ago, Dan has provided ex...
Aptar Names Vanessa Kanu, A Finance Veteran with Over 25 Years of Experience, as Next CFO AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Bob Kuhn, Executive Vice President and Chief Financia...
AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported solid second quarter results driven by continued growth of the company’s proprietary drug delivery systems and margin improvement. Reported sales increas...